Yao Zhang

Short-term right heart reverse remodeling with vericiguat in HFrEF: reductions in pulmonary arterial pressure and chamber dimensions

Background Heart failure is the end-stage of various cardiovascular diseases. Although a variety of drugs have slowed down the progression of the disease, the prognosis of heart failure patients remains unsatisfactory. Vericiguat can improve left ventricular function, but there is relatively less research on its effect...